Allosteric activation of the protein kinase PDK1 with low molecular weight compounds

被引:95
作者
Engel, Matthias
Hindie, Valerie
Lopez-Garcia, Laura A.
Stroba, Adriana
Schaeffer, Francis
Adrian, Iris
Imig, Jochen
Idrissova, Leila
Nastainczyk, Wolfgang
Zeuzem, Stefan
Alzari, Pedro M.
Hartmann, Rolf W.
Piiper, Albrecht
Biondi, Ricardo M.
机构
[1] Univ Saarland, Dept Internal Med 2, Res Grp PhosphoSites, D-66421 Homburg, Germany
[2] Univ Saarland, Dept Pharmaceut & Med Chem, Res Grp PhosphoSites, D-66421 Homburg, Germany
[3] Inst Pasteur, Struct Biochem Unit, F-75015 Paris, France
[4] Univ Saarland, Dept Biochem Med, D-6600 Homburg, Germany
关键词
AGC kinase; PDK1; PIF-pocket; protein conformation; protein phosphorylation;
D O I
10.1038/sj.emboj.7601416
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Organisms rely heavily on protein phosphorylation to transduce intracellular signals. The phosphorylation of a protein often induces conformational changes, which are responsible for triggering downstream cellular events. Protein kinases are themselves frequently regulated by phosphorylation. Recently, we and others proposed the molecular mechanism by which phosphorylation at a hydrophobic motif (HM) regulates the conformation and activity of many members of the AGC group of protein kinases. Here we have developed specific, low molecular weight compounds, which target the HM/PIF-pocket and have the ability to allosterically activate phosphoinositide-dependent protein kinase 1 (PDK1) by modulating the phosphorylation-dependent conformational transition. The mechanism of action of these compounds was characterized by mutagenesis of PDK1, synthesis of compound analogs, interaction-displacement studies and isothermal titration calorimetry experiments. Our results raise the possibility of developing drugs that target the AGC kinases via a novel mode of action and may inspire future rational development of compounds with the ability to modulate phosphorylation-dependent conformational transitions in other proteins.
引用
收藏
页码:5469 / 5480
页数:12
相关论文
共 31 条
[1]   A 3-phosphoinositide-dependent protein kinase-1 (PDK1) docking site is required for the phosphorylation of protein kinase Cζ (PKCζ) and PKC-related kinase 2 by PDK1 [J].
Balendran, A ;
Biondi, RM ;
Cheung, PCF ;
Casamayor, A ;
Deak, M ;
Alessi, DR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (27) :20806-20813
[2]   Phosphoinositide-dependent protein kinase 1, a sensor of protein conformation [J].
Biondi, RM .
TRENDS IN BIOCHEMICAL SCIENCES, 2004, 29 (03) :136-142
[3]   The PIF-binding pocket in PDK1 is essential for activation of S6K and SGK, but not PKB [J].
Biondi, RM ;
Kieloch, A ;
Currie, RA ;
Deak, M ;
Alessi, DR .
EMBO JOURNAL, 2001, 20 (16) :4380-4390
[4]   High resolution crystal structure of the human PDK1 catalytic domain defines the regulatory phosphopeptide docking site [J].
Biondi, RM ;
Komander, D ;
Thomas, CC ;
Lizcano, JM ;
Deak, M ;
Alessi, DR ;
van Aalten, DMF .
EMBO JOURNAL, 2002, 21 (16) :4219-4228
[5]   Identification of a pocket in the PDK1 kinase domain that interacts with PIF and the C-terminal residues of PKA [J].
Biondi, RM ;
Cheung, PCF ;
Casamayor, A ;
Deak, M ;
Currie, RA ;
Alessi, DR .
EMBO JOURNAL, 2000, 19 (05) :979-988
[6]   Signalling specificity of Ser/Thr protein kinases through docking-site-mediated interactions [J].
Biondi, RM ;
Nebreda, AR .
BIOCHEMICAL JOURNAL, 2003, 372 :1-13
[7]   Oncogenic kinase signalling [J].
Blume-Jensen, P ;
Hunter, T .
NATURE, 2001, 411 (6835) :355-365
[8]   Protein kinases - the major drug targets of the twenty-first century? [J].
Cohen, P .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (04) :309-315
[9]   In vivo role of the PIF-binding docking site of PDK1 defined by knock-in mutation [J].
Collins, BJ ;
Deak, M ;
Arthur, JSC ;
Armit, LJ ;
Alessi, DR .
EMBO JOURNAL, 2003, 22 (16) :4202-4211
[10]   In vivo role of the phosphate groove of PDK1 defined by knockin mutation [J].
Collins, BJ ;
Deak, M ;
Murray-Tait, V ;
Storey, KG ;
Alessi, DR .
JOURNAL OF CELL SCIENCE, 2005, 118 (21) :5023-5034